Epidermal growth factor (EGF), an endogenous mitogenic peptide, has recently been shown to be a potent vasoconstrictor of vascular smooth muscle. In view of its potential role in proliferative and infl tory renal glomerular diseases, we examined the effects of EGF both on cultured rat mesangial cells and on in vivo glomerular hemodynamics. Mesangial cells possess specific, saturable EGF receptors of differing affinities, with Kd's of 0.1 and 1.7 nM, respectively. EGF produced a rapid increase in intracellular pH of 0.12±0.01 pH U, which was sodium dependent and amiloride inhibitable. The addition of EGF to mesangial cells cultured on either glass or dimethylpolysiloxane substratum induced reproducible cell contraction.
Introduction
Epidermal growth factor (EGF)' is a 6,000 mol wt peptide first isolated by Cohen from mouse submaxillary gland (1) . Be-cause of its actions to accelerate eyelid opening and incisor formation in newborn rodents and its well-documented ability to promote mitogenesis in a wide variety of epithelial and mesenchymal cells in culture, EGF has been considered the prototypical "growth factor" (2) . In vivo, it has been shown to mediate maturation of palatal and intestinal epithelia and to accelerate wound and gastric ulcer healing and liver regeneration (3) (4) (5) . These actions of EGF are mediated by interaction of the peptide with specific cell surface receptors (6) .
In addition to its well-documented growth promoting activity, EGF possesses a number of other potentially important biologic effects. These include its ability to inhibit gastric acid secretion and to stimulate arachidonate metabolism (7, 8) . Of relevance to the present studies is the recent demonstration that EGF can serve as a potent constrictive agent for vascular smooth muscle (9, 10) .
Glomerular mesangial cells are smooth muscle-like cells of mesenchymal origin. They contain actin and myosin (11) and serve as target cells for a number of vasoactive hormones and autacoids (12) . Their contractile function is considered to be an important regulatory mechanism in the control of glomerular filtration (13) . In view of the described effects of EGF on smooth muscle cell function (9, 10, 14) , its demonstrated presence in renal tissue, and of the potential for its release from platelets and other cellular elements during glomerular injury (15) , the present studies were designed to investigate, in vivo and in vitro, the effects ofEGF on mesangial cell function. Our studies demonstrate that mesangial cells in culture possess specific receptors for EGF, and that EGF activates Na+/H+ exchange in these cells. Furthermore, addition of EGF induces contraction of cultured mesangial cells. In addition, in vivo glomerular micropuncture studies reveal that EGF, when infused into the renal artery, causes a reversible fall in the GFR due mainly to a profound reduction of the glomerular capillary ultrafiltration coefficient (Kf), a phenomenon most likely mediated by mesangial cell contraction (16) . Of interest, and in keeping with its known capacity to contract vascular smooth muscle (9, 10) , EGF also led to constriction ofpre-and postglomerular arterioles, thus decreasing glomerular perfusion.
Methods
Rat mesangial cells were isolated and cultured as previously described (17) . The following criteria were used to establish the identity of these concentration in the surface efferent arteriolar blood plasmas; EGF, epidermal growth factor, FF, filtration fraction; Kf, glomerular capillary ultrafiltration coefficient; PE, pressure in surface efferent arterioles; PGc, pressure in surface glomerular capillaries; PT, pressure in proximal tubules; pH,, intracellular pH; (^, initial glomerular capillary plasma flow; RA, resistance of single afferent arterioles; RE, resistance ofsingle efferent arterioles; RPF, renal plasma flow; SNFF, single nephron FF; SNGFR, single nephron glomerular filtration rate; TGF-a, transforming growth factor alpha; TMAC1, tetramethylammonium chloride; rA, colloid osmotic pressure. cells: (a) a stellate or spindle morphology noted using phase contrast microscopy, (b) electron microscopic demonstration of bundles of microfilaments and elongated nuclei, (c) characteristic staining of the filaments with antimyosin antibodies and FITC labeled phalloidin, (d) insensitivity to puromycin and lack ofstaining for Factor VIII antigen. The studies were performed upon cloned mesangial cells from passages [8] [9] [10] [11] [12] . The mesangial cells were routinely grown in RPMI 1640, supplemented with 20% FCS, penicillin (100 U/ml), and streptomycin (100 lsg/ml). 24 (18) . Furthermore, angiotensin II, which is known to decrease GFR and constrict mesangial cells, has recently been shown to activate Na+/H' exchange in smooth muscle cells (19, 20) . Therefore, the effects ofEGF on pHi regulation in cultured mesangial cells was studied. Measurement of pHi was performed using mesangial cells grown on glass coverslips. Cells were exposed for 1 h to 5 gM 2'7'-bis(2-carboxyethyl)-5(and-6) carboxyfluorescein (BCECF) in a nominally bicarbonate free medium, consisting of 140 mM NaCl, 5 mM KCI, 1.5 mM CaCI2, 1.0 mM MgCl2, 10 mM glucose, 10 mM Hepes, pH 7.40. Fluorescent measurements were performed using a Nikon DIAPHOT TMD inverted microscope with an epifluorescence attachment and a Nikon PI Photometer (Nikon, Inc., Garden City, NY Contractility studies. Early passage (1-3) rat mesangial cells were seeded either directly on glass coverslips or upon glass coverslips coated with dimethylpolysiloxane (60,000 centistokes), using the method of Harris et al. (22) and Singhal et al. (23) . Experiments were conducted 24 h after seeding and were performed using a camera equipped inverted Nikon microscope. The temperature of the bath was maintained at 370C. by means of a microscope-associated environmental chamber (Nikon).
Micropuncture studies. All experiments were performed on anesthetized adult male Munich-Wistar rats weighing 234-270 g that were prepared for micropuncture according to protocols described previously (24 King, NC) to allow for continuous monitoring of renal blood flow rate. Homologous rat plasma was administered intravenously at a rate of 10 ml/kg per h for 45 min, which was followed by a reduction in infusion rate to 1.5 ml/kg per h for the remainder of the experiment. This protocol of plasma administration has been shown previously to replace adequately surgically-induced plasma losses, thus maintaining euvolemia (24) .
In all experiments, micropuncture measurements were performed 45 Group I (n = 5). In this group, whole kidney and micropuncture measurements were performed during an initial baseline period and then repeated during a second period in which the EGF vehicle infusion (0.9% NaCl) in the left renal artery was maintained. These animals served as time controls.
Group II (n = 9). In this group, the same measurements were performed during an initial baseline period and were then repeated during intrarenal arterial administration of purified mouse EGF in a dose of 500 ng/kg per min for -30 min at a rate equal to 0.025 ml/min. This dose was designed to achieve an intrarenal vascular concentration of EGF equal to 3 nM, a value close to our calculated Kd obtained in the in vitro binding studies described above (see Results).
Analytical. Colloid osmotic pressure ofplasma entering and leaving glomerular capillaries was estimated from values for protein concentration (C) in femoral arterial (CA) and in surface efferent arteriolar (CE) blood plasmas. Colloid osmotic pressure (ir) was calculated according to the equation derived by Deen et al. (25) . Values for CA, and thus for rA, and for femoral arterial plasma are taken as representative for C and X in the afferent end of the glomerular capillary network. These estimates of pre-and postglomerular protein concentration permit the calculation of single nephron filtration fraction (SNFF), glomerular capillary Kf, resistance of single afferent (RA) and efferent (RE) arterioles, and initial glomerular capillary plasma flow (QA) using equations described in detail elsewhere ( 16) . (Fig. 1) and at 230C. (data not shown). There was 73±8% specific binding at 4VC (n = 4) and 83±4% specific binding at 230C (n = 9). Scatchard transformation of the binding of '25I-EGF at 40C revealed a nonlinear Scatchard plot (inset, Fig. 1 ), which was consistent with the presence of two binding sites of differing affinities (27) . The (Fig. 2) . In addition, transforming grvth factor alpha (TGF-a), a known functional homologue of EGF (28) , also competed with '25I-EGF for binding to mesangial cells over a concentration range of lO-1-lI-7 M (Fig. 2) . In contrast, there was no inhibition of '25I-EGF binding by To determine whether extracellular Na+ was necessary for the recovery of pHi, the mesangial cells were acidified by the NH4C1 loading method originally described by Boron and DeWeer (29) . After exposure for 7 min to 50 mM NH4Cl in the NaCl buffer, the medium was then changed to TMACl-containing medium without NH4CI, and intracellular acidification ensued. (Fig. 3) No recovery of pHi was noted during the succeeding 10 min. When the cells were then returned to an NaCl-containing medium, there was recovery of pHi, with a rise close to baseline pH. The effects of EGF on the pHi of cultured mesangial cells are shown in Fig. 4 A. When EGF was added to cells in the NaCl-containing solution, intracellular alkalinization was noted within 1-5 min. There were no significant differences in the maximal alkalinization induced by the administration of EGF over the concentration range of 1-30 nM, with an increase of pHi of 0.12±0.01 pH units (n = 11). The alkalinization was largely inhibited by either the preincubation in, or simultaneous addition of, 0.5 or 1.0 mM amiloride (Fig. 4 B) . Furthermore, no alkalinization response was noted in cells incubated in TMACl-containing medium (Fig. 4 C) . When the cells were subsequently returned to NaCl-containing medium, pHi recovery was stimulated more than it was in mesangial cells that were not exposed to EGF. In this experiment, there was at least a 2.3-fold increase in the initial rate ofpH recovery compared with similarly treated control cells that had not been exposed to EGF (0.34 vs. 0.148 ApH units/min).
Contraction studies. When mesangial cells grown on glass coverslips were exposed to EGF, there were significant changes in cell morphology within 10 min (Fig. 5, A-C) . Noticeable shape alterations in response to EGF were noted in mesangial cells studied on three separate occasions, while no significant change in morphology could be detected in time controls (not shown).
Because shape changes in mesangial cells grown upon glass coverslips may be secondary to either contraction or detachment from the substratum (23) , further studies were performed using mesangial cells grown on a silicone rubber substratum. Contraction and relaxation were assessed by changes in the pattern of substratum wrinkling, as described previously by Singhal et al. (23) . The administration of EGF induced a time-dependent increase in wrinkling (Fig. 5, D-E) , which correlates with cell contraction measurements. Dibutryl cAMP administration led to mesangial cell relaxation (Fig. 5 , G-H) as previously described (23) . The subsequent administration of EGF led to a partial recovery of the original pattern of wrinkling (Fig. 5 I) Despite the above-noted reductions in glomerular plasma flow and filtration rates, EGF administration was not associated with significant changes in PGC (50±5-54±2 mmHg), PT (11±1-10±1 mmHg), AP (38±5-37±8 mmHg), or WE (35.1±4.6-29.4±3.8 mmHg). Calculation of resistances across the afferent (RA) and efferent (RE) arterioles, however, revealed significant increases in both values: from 1.97±0.31 to 2.65±0.36 1010 dyn-* scm-5 (P < 0.05) and from 1.19±0.11 to 2.00±0.15 1010 dyn * s * cm-5 (P < 0.05), respectively. Of particular interest, EGF infusion resulted in a highly significant reduction in Kf, which fell from 0.100±0.019 to 0.031±0.007 nl/(s. mmHg), P < 0.025.
In four animals that were followed for an additional 30 min after stopping the EGF infusion, there was near-complete recovery ofRPF and complete recovery ofGFR to 3.47 and 1.37 ml/min, respectively. The EGF-induced changes in glomerular hemodynamics are summarized in Fig. 6 (36, 37) . In our studies, incubation of rat glomerular mesangial cells with EGF led to the development of intracellular alkalinization, an effect inhibited by amiloride or by extracellular Na' removal (Fig. 4) EGF-induced activation of Na+/H' exchange was further suggested by the demonstrated ability of this peptide to stimulate potently the rate 'of recovery of these cells from experimentally induced intracellular acidification (Figs. 3 and 4 C ).
Activation of Na+/H' exchange is a common feature of growth factor-mediated cellular activation (38) , and EGF has been demonstrated previously to activate Na+/H' exchange in a number of other cell culture systems (17, 39) . The extension of this observation to the glomerular mesangial cell, however, is of particular interest not only with regard to its implications for proliferative responses, but also in view of the increasingly important role assigned to these cells in the regulation of the functional aspects ofglomerular physiology, namely the rate of glomerular ultrafiltration. The demonstration that EGF administration induced the contraction of cultured mesangial cells (Fig. 5) , provided further suggestive evidence that this peptide might modulate glomerular hemodynamics in vivo. For this reason, we sought to examine the effect ofexogenously administered EGF upon Kf, a determinant of SNGFR thought to be dynamically modulated through mesangial cell contraction and relaxation (16) .
As shown by the data obtained in group II rats (Table II) , intrarenal arterial administration ofEGF, in a dose designed to achieve an intrarenal vascular concentration of 3 nM, did indeed result in a 70% reduction in Kf. Of interest in this regard is the equipotency of the Kflowering effect of EGF as compared with that previously reported for angiotensin II (40).
Hormone-induced changes in Kf are thought to be mediated, at least in part, by mesangial cell contraction, thereby altering effective surface area for filtration, although concomitant changes in glomerular-endothelial cell permeability have not been rigorously excluded. (11, 16) The observation that agents that lead to decreases in Kf in vivo, also induce the contraction of cultured mesangial cells in vitro (41) , is further evidence that these cells have a role in modulating GFR. It is of interest that EGF has previously been reported to induce rapid rounding and cytoskeletal reorganization ofhuman carcinoma A-43 1 cells (42). More importantly, our own demonstration that cultured glomerular mesangial cells possess specific receptors for EGF and that they contract in response to EGF administration, further supports the notion that the observed in vivo responses represent EGF-induced contraction of these cells.
Little is known about the mechanisms of cellular signal transduction of agents that decrease Kf. Recent studies in cultured vascular smooth muscle cells have demonstrated that angiotensin II mediates increased Na' influx and intracellular alkalinization via the activation of Na+/H' exchange (18, 19) .
A similar activation of Naf/H' exchange in cultured mesangial cells by vasopressin has been reported in preliminary form (37) . That intracellular alkalinization may play a role in the signal transduction of vasoconstrictive agents is further suggested by the observation that amiloride, which blocks Na`/H+ exchange (43), serves as a vasodilator (44) , and that NH4Cl-induced intracellular alkalinization stimulates (45), and C02-induced intracellular acidification inhibits (18) the contraction of rat aorta. NH4Cl-induced intracellular alkalosis also stimulates contraction of cardiac muscle cells (46). The demonstration in the present studies, therefore, of EGF-induced activation of Na+/H+ exchange in rat mesangial cells suggests that such activation may represent an important step in the signal transduction pathway for the contractile, as well as the mitogenic, responses of these cells to EGF.
The demonstration of EGF-induced pre-and postglomerular arteriolar constriction in group II rats is consistent with the studies of Berk et al. and Muramatsu et al., who found that EGF induces contraction of vascular smooth muscle in rat aorta and ileocolic arteries (9, 10) . In addition, it has been reported that intravenous EGF infusion in awake sheep causes al. and Muramatsu et al. demonstrated a direct constrictive effect of EGF upon isolated artery preparations (9, 10) . Taken together, these data establish EGF as a potent vasoactive substance with a potential to adversely affect glomerular perfusion and filtration functions when sufficient concentrations of EGF, or its functional analogue, TGF-a, are achieved within the glomerular microcirculation.
Oka and Orth determined that the concentration of EGF in human whole blood was 250-300 pg/ml (40-50 pM); essentially all of the circulating EGF was associated with platelets (15) . Although the concentrations of EGF used in the present studies are 50-100 times higher than the concentrations in human blood, release of platelet-associated EGF from alpha secretory granules during platelet aggregation may provide much higher local levels ofthe peptide at the site ofinjury. In addition, in human bone marrow, EGF has been immunohistochemically localized to cells resembling monocytes (49 (28) . The present studies confirm that TGF-a competes for the EGF binding site in cultured mesangial cells. TGF-a also activated Na+/H+ exchange in these cells (data not shown).
It has been shown that removal of the salivary glands and duodenum, the presumed sources of synthesis of circulating EGF in rats, does not affect urinary EGF levels, which suggests that the kidney is a major source ofpeptide synthesis (50) . This is further supported by the studies of Rall et al. (51) , which demonstrate the presence of messenger RNA for the EGF precursor pre-proEGF in renal tissue, as well as by other studies that demonstrate high renal EGF levels by immunohistochemical staining (49) . Thus, its release from activated platelets, as well as its endogenous renal production, render the present observations on the actions of EGF on glomerular mesangial cells potentially highly relevant with respect to the control of glomerular function under physiologic and/or pathophysiologic conditions. Examination ofurinary flow rates and electrolyte excretion rates during EGF administration (Table II) reveals that although GFR fell by 35-40%, urinary flow rate did not decrease during EGF infusion. This finding, which suggests increased water clearance, is highly consistent with previous observations by Scoggins et al. (47) ofincreased urine flow rates during lower doses of systemic EGF infusion, and with the demonstration by Breyer and co-workers of a potent inhibitory effect for EGF on the hydroosmotic action of vasopressin in isolated rabbit cortical collecting tubules (52) .
A decrease in GFR is usually an early event in the clinical course of a variety of glomerulonephritidies. In acute experimental glomerulonephritis, glomerular micropuncture has revealed that decreases in Kf mediate the fall in GFR (53) . Subsequent mesangial cell proliferation is also seen in a variety of glomerulonephritidies (34) . Since local glomerular EGF levels may be expected to be elevated during the acute phase of proliferative glomerulonephritis, it is possible that EGF may participate in the mediation of both the acute hemodynamic alterations as well as the subsequent mesangial proliferation. This possibility is highlighted by the recent demonstration of elevated urinary EGF levels in patients with acute proliferative forms of glomerulonephritis (35). That EGF is one of the mediators of normal or compensatory glomerular growth, is also an intriguing possibility.
In summary, the present studies demonstrate that cultured rat glomerular mesangial cells possess specific receptors for EGF. Exposure of these cells to physiologic concentrations of EGF results in an in vitro functional response characterized as activation of Na+/H+ exchange and induction of intracellular alkalinization. Administration of EGF leads to contraction of cultured mesangial cells. In concert with these in vitro effects, selective intrarenal administration of the peptide in vivo leads to a profound reduction in the glomerular capillary ultrafiltration coefficient which is thought to be mediated, in large part, by changes in glomerular surface area secondary to mesangial cell contraction. The latter response, in combination with significant EGF-induced constriction of both preglomerular and postglomerular arterioles, results in acute and reversible reductions in the rates of glomerular filtration and perfusion. These demonstrated effects of EGF on mesangial cell function and glomerular microcirculatory dynamics raise the intriguing possibility of a potentially significant role for this mitogenic peptide in the functional, as well as the proliferative, responses of the glomerulus during inflammatory injury.
